Page 375 - Effectiveness News Today

>> so the question is what degree of effectiveness -- >> sorry. i just wanted to -- yeah, theres a lag there. i just wanted to jump in when you talk about the data because there was data from pfizer saying immunity waned after six months. israeli scientists presented evidence, supporting the need for boosters. that wasnt enough? >> so that waning was a cross vector. and its showing people who had a response, people who are immunoco immunocompromised, et cetera. but that waning did not occur amon...

Informed scientific debate you would want to see experts having ahead of a big public health decision. ultimately, the panel had to answer this question today. do the safety and effectiveness data from the clinical trials support approval of a booster dose administered at least six months after completion of the primary series for use in individuals 16 years and older. in other words should everybody over 16 get a gooser shot? the answer in the end was no. the advisory panel voted against recomm...

Neutralizing antibodies. we knew this was coming. on wednesday, the israelis published in the new england journal of medicine an important study showing that those 60 years of age who only receive two doses were going into the hospital at pretty high rates and lots of breakthrough covid infections where as if they got a third immunization, they did a much better and tenfold decline in cases. at a minimum, i would have thought they would have brought that down to 60 years of age and then today, t...

In manhattan outside pfizer headquarters and chris jansing outside a hospital in raleigh, north carolina. gabe, first to you. that advisory panel has been meeting for three hours. take us through what we know so far and the stakes for millions of people. do you get a shot? do you not get a shot? what comes next? >> yeah. thats right, andrea. a lot of confusion over the last several days and this is highly contentious over the medical community. this advisory panel meeting set to issue a recommen...

But its vaccine continues to be highly effective in preventing hospitalization and preventing serious illness. >> this debate over boosters, does that erode the public confidence in vaccines. >> its normal for scientists to not necessarily have consensus around a specific issue. the problem is were in a toxic environment because of all the aggression coming from antivaccine groups and they use any kind of difference in opinion as a wedge issue. >> with volumes of vaccine data now published a new...

Against severe disease and death. a third shot can increase immunity against the milder breakthrough infections and it all adds some uncertainty in terms of what the full fda committee is going to do. let hes bring in to our coverage infectious disease physician, founding director of the center for emerging infectious disease policy and research at boston university and lucky for us an msnbc contributor. the founding director of the national center for disaster preparedness and lucky for us an m...

But even aside from that just looking at the data is what theyre going to really be doing at the advisory committee meeting to try and figure out really the answers to four major questions. and i sort of laid them out here. theres going to be a lot of things that theyre going to sort of want to address, but the four major questions, how much is immunity really waning? we talked about this a bit yesterday, and there are some studies that suggest it wanes but maybe not in a linear way. pfizer had ...

Only followed the group for 25 days after the vaccination, so this week in the morbidity and mortality report, shows that the data of the effectiveness of the pfizer vaccine declines from 25 days out down to 77% for hospitalizations which is significant. so i think that based on just those two pieces of information and publications, i think that there is a high likelihood that the committee is going to recommend a booster in some form, but what i dont know as dr. fauci mentioned in the introduct...

It is great to be with you. im geoff bennett in los angeles today. as we come on the air, we are awaiting a critical vote on booster shots that could come at any time today. an fda advisory panel is currently debating the data, the research and the need for a third round of covid shots which the biden administration had hoped to begin offering on monday. but what happens at the end of this marathon day-long discussion could derail that plan or limit it to far fewer americans. pfizer which would ...

Six months after the second dose as protection from infection begins to wane. but its vaccine is hoyly effective in preventing hospitalization and serious illness. its most critical function. >> this debate over boosters, is that a road of public confidence in vaccines? >> its normal for scientists to not necessarily have consensus around a specific issue. the problem is, were in a very toxic environment now because of all the aggression coming from anti-vaccine groups and they use any kind of d...